Cleared Traditional

K002514 - CADHEALTH SYSTEM, MODEL CHP-001

K002514 is an FDA 510(k) clearance for CADHEALTH SYSTEM, manufactured by Caduceus Health Care , Ltd.. The device is a Class 2 Cardiovascular device with product code DRG cleared through the Traditional 510(k) pathway after a 289-day FDA review.

K002514 · Caduceus Health Care , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2001
Decision
289d
Days
Class 2
Risk

K002514 is an FDA 510(k) clearance for the CADHEALTH SYSTEM, MODEL CHP-001. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Caduceus Health Care , Ltd. (Halifax Ns, CA). The FDA issued a Cleared decision on May 31, 2001 after a review of 289 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Caduceus Health Care , Ltd. devices

FDA 510(k) Submission Details - K002514

510(k) Number K002514 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2000
Decision Date May 31, 2001
Days to Decision 289 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
164d slower than avg
Panel avg: 125d · This submission: 289d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRG Device Classification - Class 2, Special Controls

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 178
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K002514.
CARECOMPANION PATIENT STATION & NURSE STATION
K022274 · Neptec Design Group, Ltd. · May 2003
THE M3810A PHILIPS TELEMONITORING SYSTEM WITH M3812B TELESTATION (M310A/12B)
K023749 · Philips Medical Systems · Nov 2002
EMS TELEMEDICINE OPTION (FOR GEMS SERIES 4000)
K013533 · General Devices · Jan 2002
ROSETTA-LT/ROSETTA-RX
K002089 · General Devices · Nov 2000
MPT 24 AND VITAL VIEW 24
K000276 · Criticare Systems, Inc. · Mar 2000
AVIVA SYSTEM, MODEL SL1010
K993550 · American Telecare, Inc. · Jan 2000